Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ferrandina

Showing results (71-80 of 176) with videos related to

Pageof 18
Sort By:
Cancer Letters|December 24, 1992
Cathepsin D in primary squamous laryngeal tumors: correlation with clinico-pathological parameters and receptor statusG Ferrandina, G Scambia, P Benedetti Panici, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 13, 2005
Microsatellite instability is not related to response to cisplatin-based chemotherapy in cervical cancerA Ercoli, G Ferrandina, M Genuardi, et al.
Cancer|December 18, 2001
Systematic pelvic and aortic lymphadenectomy in elderly gynecologic oncologic patientsR Giannice, T Susini, G Ferrandina, et al.
International Journal of Cancer|August 4, 1998
Growth-inhibitory effect of tamoxifen and quercetin and presence of type II estrogen binding sites in human laryngeal cancer cell lines and primary laryngeal tumorsG Ferrandina, G Almadori, N Maggiano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1997
Glutathione S-transferase activity in epithelial ovarian cancer: association with response to chemotherapy and disease outcomeG Ferrandina, G Scambia, G Damia, et al.
Gynecologic Oncology|May 1, 1994
Immunosuppressive acidic protein (IAP) and squamous cell carcinoma antigen (SCC) in patients with cervical cancerF Battaglia, G Scambia, P B Panici, et al.
Gynecologic Oncology|August 14, 2013
Introduction of staging laparoscopy in the management of advanced epithelial ovarian, tubal and peritoneal cancer: impact on prognosis in a single institution experienceA Fagotti, G Vizzielli, F Fanfani, et al.
Gynecologic Oncology|July 6, 2010
Is adjuvant chemotherapy indicated in stage I pure immature ovarian teratoma (IT)? A multicentre Italian trial in ovarian cancer (MITO-9)G Mangili, G Scarfone, A Gadducci, et al.
British Journal of Cancer|January 19, 2005
Survivin expression in ovarian cancer and its correlation with clinico-pathological, surgical and apoptosis-related parametersG Ferrandina, F Legge, E Martinelli, et al.
British Journal of Cancer|July 17, 1999
hMSH2 and GTBP expression in advanced stage epithelial ovarian cancerA Ercoli, G Ferrandina, G Raspaglio, et al.
Pageof 18

Showing results (71-80 of 176) with videos related to

Sort By:
Pageof 18
Cancer Letters|December 24, 1992
Cathepsin D in primary squamous laryngeal tumors: correlation with clinico-pathological parameters and receptor statusG Ferrandina, G Scambia, P Benedetti Panici, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 13, 2005
Microsatellite instability is not related to response to cisplatin-based chemotherapy in cervical cancerA Ercoli, G Ferrandina, M Genuardi, et al.
Cancer|December 18, 2001
Systematic pelvic and aortic lymphadenectomy in elderly gynecologic oncologic patientsR Giannice, T Susini, G Ferrandina, et al.
International Journal of Cancer|August 4, 1998
Growth-inhibitory effect of tamoxifen and quercetin and presence of type II estrogen binding sites in human laryngeal cancer cell lines and primary laryngeal tumorsG Ferrandina, G Almadori, N Maggiano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1997
Glutathione S-transferase activity in epithelial ovarian cancer: association with response to chemotherapy and disease outcomeG Ferrandina, G Scambia, G Damia, et al.
Gynecologic Oncology|May 1, 1994
Immunosuppressive acidic protein (IAP) and squamous cell carcinoma antigen (SCC) in patients with cervical cancerF Battaglia, G Scambia, P B Panici, et al.
Gynecologic Oncology|August 14, 2013
Introduction of staging laparoscopy in the management of advanced epithelial ovarian, tubal and peritoneal cancer: impact on prognosis in a single institution experienceA Fagotti, G Vizzielli, F Fanfani, et al.
Gynecologic Oncology|July 6, 2010
Is adjuvant chemotherapy indicated in stage I pure immature ovarian teratoma (IT)? A multicentre Italian trial in ovarian cancer (MITO-9)G Mangili, G Scarfone, A Gadducci, et al.
British Journal of Cancer|January 19, 2005
Survivin expression in ovarian cancer and its correlation with clinico-pathological, surgical and apoptosis-related parametersG Ferrandina, F Legge, E Martinelli, et al.
British Journal of Cancer|July 17, 1999
hMSH2 and GTBP expression in advanced stage epithelial ovarian cancerA Ercoli, G Ferrandina, G Raspaglio, et al.
Pageof 18